Literature DB >> 27450097

Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.

Ya Zhang1, Xiaomei Zhang1, Dongsheng Liu2, Honghao Wang3, Suyue Pan1, Dongmei Wang1, Xiong Chen1.   

Abstract

Multiple sclerosis (MS) and neuromyelitis optica (NMO) are inflammatory demyelinating diseases of the central nervous system. In this study, the important role of fibrinogen in demyelination diseases was investigated. Plasma prothrombin time (PT), activated partial thrombin time (APTT), thrombin time (TT), fibrinogen, were measured among 189 patients with MS/NMO and 80 non-inflammatory neurological disease subjects as a control group. The Expanded Disability Status Scale (EDSS) was used to measure neurological impairment and disability of MS/NMO group. Fibrinogen levels were elevated in NMO and MS groups comparing with control ones, which was statistically associated with the severity of disease. Our results may lead to a better understanding of the etiopathogenesis of MS/NMO and contribute to prospects for preventions and treatments.

Entities:  

Keywords:  Axonal destruction; Demyelination disease; Fibrinogen; Microglia; Multiple sclerosis; Neuromyelitis optica

Mesh:

Substances:

Year:  2016        PMID: 27450097     DOI: 10.1007/s10072-016-2628-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

Review 1.  Fibrin mechanisms and functions in nervous system pathology.

Authors:  Ryan A Adams; Melissa Passino; Benjamin D Sachs; Tal Nuriel; Katerina Akassoglou
Journal:  Mol Interv       Date:  2004-06

Review 2.  Astrocyte-endothelial interactions at the blood-brain barrier.

Authors:  N Joan Abbott; Lars Rönnbäck; Elisabeth Hansson
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

Review 3.  Microglial physiology: unique stimuli, specialized responses.

Authors:  Richard M Ransohoff; V Hugh Perry
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

6.  Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen.

Authors:  T P Ugarova; D A Solovjov; L Zhang; D I Loukinov; V C Yee; L V Medved; E F Plow
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

7.  Human plasma fibrinogen is synthesized in the liver.

Authors:  Glenys A Tennent; Stephen O Brennan; Arie J Stangou; John O'Grady; Philip N Hawkins; Mark B Pepys
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.

Authors:  K Akassoglou; K W Kombrinck; J L Degen; S Strickland
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

10.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

Authors:  Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more
  4 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.

Authors:  Rui Vilar; Samuel W Lukowski; Marco Garieri; Corinne Di Sanza; Marguerite Neerman-Arbez; Richard J Fish
Journal:  Thromb Haemost       Date:  2020-12-10       Impact factor: 5.249

Review 3.  A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis.

Authors:  Domenico Plantone; Matilde Inglese; Marco Salvetti; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2019-01-14       Impact factor: 4.003

Review 4.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.